Strongly Disagree: Kenvue On Donald Trump Links Tylenol To Autism

A claim by President Donald Trump linking the pain reliever Tylenol (known as paracetamol in other countries) to a rise in autism rates in the U.S. has triggered a strong backlash from medical professionals, health organizations, and autism advocates. Trump's assertion, made alongside Health and Human Services Secretary Robert F. Kennedy Jr., has been widely dismissed as unsupported by scientific consensus.

The President's remarks urged pregnant women to "tough it out" and avoid Tylenol, which he claimed could cause autism. This led to immediate condemnation from the medical community, with groups like the American College of Obstetricians and Gynecologists (ACOG) stating that the claims were "irresponsible" and "not backed by the full body of scientific evidence."

Tylenol's manufacturer, Kenvue, swiftly rejected the claims, emphasizing that "independent, sound science clearly shows that taking acetaminophen does not cause autism." The company and leading medical groups stressed that withholding the medication could pose a greater risk to mothers and unborn babies by leaving conditions like fever untreated. Acetaminophen is a pain reliever and fever reducer, and is widely considered the safest option for pregnant women when used as directed.

"We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers," the company told BBC in a statement.

Experts have consistently stated that autism spectrum disorder (ASD) has no single cause, and is a complex neurodevelopmental condition influenced by a combination of genetic and environmental factors.

The scientific literature on a potential link between Tylenol and autism is mixed and inconclusive. While some smaller observational studies have suggested a possible association, they have not established a direct causal relationship. A much larger and more robust 2024 study of 2.5 million Swedish siblings found no evidence of a heightened risk of autism among children whose mothers took acetaminophen during pregnancy.

The medical consensus remains that the current evidence does not support a causal link and that Tylenol remains a safe medication for pregnant women when used prudently.

Tylenol, originally launched in 1955 by McNeil Laboratories, has a history of its own controversies, including a major recall in 2010 due to manufacturing issues. However, these past events are separate from the ongoing scientific and public debate regarding its use during pregnancy.